Yu’e JIANG, Zhaoming ZHONG, Yanzhang GAO, Wei WANG, Ruimei SUN, Chuanzheng SUN. Role and Mechanism of TGF β1 in Platelet Promoting Invasion and Migration of Anaplastic Thyroid Carcinoma Cells[J]. Journal of Kunming Medical University, 2022, 43(12): 1-5. doi: 10.12259/j.issn.2095-610X.S20221201
Citation: Siqi WU, Gang CHEN, Yishuang XIAO. Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity[J]. Journal of Kunming Medical University, 2022, 43(5): 127-132. doi: 10.12259/j.issn.2095-610X.S20220513

Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity

doi: 10.12259/j.issn.2095-610X.S20220513
  • Received Date: 2022-01-11
    Available Online: 2022-05-19
  • Publish Date: 2022-05-27
  •   Objective  To observe the effect of treatment for aggressive posterior retinopathy of prematurity (A-ROP).   Methods  Retrospective case studies were made and 55 premature infants (110 eyes) who were diagnosed as A-ROP were selected from Kunming Children’s Hospital from July 2015 to May 2020, including 35 females and 20 males. The gestational age ranged from 24 to 37 (29.47±2.30) weeks and the birth weight ranged from 730 to 2250 (1322.09±322.75) g.All children received intravitreous injection of ranibizumb 10 mg/ml 0.03 ml (IVR) within 48 hours after the diagnosis. After IVR, the systemic and ocular adverse effects were observed during the follow-up and checked the retina after 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year for six times. Retinal Laser photocoagulation (LP) therapy was given to those recurrent eyes or not responding to ranibizumb. The time from IVR to LP were 26~48 (36.58±5.59) days. The effectiveness of IVP and the LP after IVR were divided into two groups to compare the gestational age, maternal age, length of NICU hospital stay, birth weight and the duration of oxygen inhalation, and compared the differences by t-test.   Results  47.3% of eyes (52 eyes of 110 ) after IVR were effective, the lesions completely subsided, the additional lesions disappeared, and there was no neovascularization. The retinal vessels developed to zone 3. 57 eyes (51.8%) were treated with supplementary retinal LP. After IVR combined with LP, 1 eye (0.9%) had the recurrence, cataract combined with partial retinal detachment, vitrectomy and lensectomy were performed, and the retina was completely restored after the surgery. No ocular or systemic adverse reactions occurred in all pantients during the follow-up.  Conclusion  The comprehensive treatment of IVR and LP in A-ROP is effective.
  • [1]
    尹虹,黎晓新,姜燕荣,等. 极低体重早产儿视网膜病变的临床研究[J]. 中华眼底病杂志,2005,21(5):275-277. doi: 10.3760/j.issn:1005-1015.2005.05.002
    [2]
    尹虹,黎晓新. 与早产儿视网膜病变自然退行有关因素的分析[J]. 中华实验眼科杂志,2006,24(6):643-646. doi: 10.3760/cma.j.issn.2095-0160.2006.06.021
    [3]
    中华医学会眼科学会分会眼底病组. 中国早产儿视网膜病变筛查指南[J]. 中华眼科杂志,2014,50(12):933-935. doi: 10.3760/cma.j.issn.0412-4081.2014.12.017
    [4]
    None. The international of retinopathy of prematurity revisited[J]. Arch Ophthalmol,2005,123(7):991-999. doi: 10.1001/archopht.123.7.991
    [5]
    刘文. 早产儿视网膜病变[J]. 临床眼底病,2015,2(1):355.
    [6]
    Chiang M F,Quinn G E,Fielder A R,et al. International classification of retinopathy of prematurity,third edition[J]. Ophthalmology,2021,128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031
    [7]
    陈锋,项道满,王建勋,等. 玻璃体注射Bevacizumab治疗阈值期早产儿视网膜病变的疗效分析[J]. 中国斜视与小儿眼科杂志,2016,24(2):25-28. doi: 10.3969/J.ISSN.1005-328X.2016.02.008
    [8]
    陈锋,项道满,王建勋,等. 不同剂量Bevacizumab治疗阈值前期I型早产儿视网膜病变的疗效分析[J]. 中国斜视与小儿眼科杂志,2018,26(4):25-26.
    [9]
    Chan-Ling T,Gock B,Stone J. The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia’ is the stimulus for normal retinal vasculogenesis[J]. Investigative Ophthalmology & Visual Science,1995,36(7):1201-14.
    [10]
    Zhang, G , Yang, M , Zeng, J , et al. (2017). Comparison of intravitreal injection of ranibizumab versus laser therapy for zone ii treatment-requiring retinopathy of prematurity[J]. Retina, 37(4): 710-717.
    [11]
    Zehetner C,Kirchmair R,Huber S,et al. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab,ranibizumab and pegaptanib in patients with age-related macular degeneration,and in patients with diabetic macular odema[J]. Br J Ophthalmol,2013,97(4):454-459. doi: 10.1136/bjophthalmol-2012-302451
    [12]
    Fierson W M,American Academy of Pediatrics Section on Ophthalmology,American Academy of Ophthalmology,et al. Screening examination of premature infants for retinopathy of prematurity[J]. Pediatrics,2013,131(1):189-195. doi: 10.1542/peds.2012-2996
    [13]
    Feng J,Qian J,Jiang Y,et al. Efficacy of primary intravitreal ranibizumab for retinopathy of prematurity in China[J]. Ophthalmology,2017,124(3):408-409. doi: 10.1016/j.ophtha.2016.10.032
    [14]
    Morin J,Luu T M,Superstein R,et al. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity[J]. Pediatrics,2016,137(4):2015-3218.
    [15]
    赵欢欢,李静,穆歌,等. 玻璃体腔注射雷珠单抗治疗早产儿视网膜病变的临床疗效[J]. 中国斜视与小儿眼科杂志,2018,26(3):22-25.
    [16]
    Björn C Harder,Schlichtenbrede F C,Baltz S V,et al. Intravitreal bevacizumab for retinopathy of prematurity:Refractive error results.[J]. American Journal of Ophthalmology,2013,155(6):1119-1124. doi: 10.1016/j.ajo.2013.01.014
    [17]
    Geloneck M M,Chuang A Z,Clark W L,et al. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment a randomized clinical trial[J]. Jama Ophthalmology,2014,132(11):1327-1333. doi: 10.1001/jamaophthalmol.2014.2772
    [18]
    Gaurav,Sanghi,Mangat,et al. Aggressive posterior retinopathy of prematurity in Asian Indian babies:Spectrum of disease and outcome after laser treatment.[J]. Retina,2009,29(9):1335-1339. doi: 10.1097/IAE.0b013e3181a68f3a
    [19]
    Mintz-Hittner H A,Kennedy K A,Chuang A Z. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity[J]. New England Journal of Medicine,2011,364(7):603-615. doi: 10.1056/NEJMoa1007374
    [20]
    Mutlu F M,Sarici S U. Treatment of retinopathy of prematurity:A review of conventional and promising new therapeutic options.[J]. International Journal of Ophthalmology,2013,6(2):228-236.
    [21]
    Hwang C K,Hubbard G B,Hutchinson A K,et al. Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity:A 5-year retrospective analysis[J]. Ophthalmology,2015,122(5):1008-1015. doi: 10.1016/j.ophtha.2014.12.017
    [22]
    Hsieh C J,Liu J W,Huang J S,et al. Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age:A prospective controlled cohort study[J]. The Kaohsiung journal of medical ences,2012,28(4):204-211. doi: 10.1016/j.kjms.2011.10.010
    [23]
    朱苾丹,李绍军. 我国早产儿视网膜病变筛查及治疗现状[J]. 中国斜视与小儿眼科杂志,2019,27(3):44-47. doi: 10.3969/J.ISSN.1005-328X.2019.03.016
    [24]
    曹贺,罗小玲,李志光,等. 激光光凝联合玻璃体腔注射低剂量雷珠单抗治疗急进型后极部ROP的疗效[J]. 国际眼科杂志,2019,19(11):1978-1981. doi: 10.3980/j.issn.1672-5123.2019.11.38
    [25]
    张国明,赵金凤. 重视儿童视网膜疾病的规范化治疗,努力提高其治疗水平[J]. 中华眼底病杂志,2020,36(8):583-589. doi: 10.3760/cma.j.cn511434-20200806-00380
  • Relative Articles

    [1] Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2025, 46(4): 1-9.
    [2] Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2024, 45(10): 36-44.  doi: 10.12259/j.issn.2095-610X.S20241006
    [3] Ya LUO, Yanting YU, Xue ZHANG, Zhongjuan WANG. A Meta-analysis of the Risk of Secondary Infection of Tocilizumab in the Treatment of COVID-19. Journal of Kunming Medical University, 2024, 45(2): 57-64.  doi: 10.12259/j.issn.2095-610X.S20240208
    [4] Shuang FANG, Libo ZHU, Ling LIU, Yanhua XU, Xue HU. Meta-analysis of the Impact of Early Enteral Nutrition on the Clinical Outcomes of Very Low Birth Weight Premature Infants. Journal of Kunming Medical University, 2024, 45(9): 129-135.  doi: 10.12259/j.issn.2095-610X.S20240920
    [5] Siqi WU, Gang CHEN, Yishuang XIAO. The Correlation between Routine Blood Indicators and Severity of Retinopathy of Prematurity. Journal of Kunming Medical University, 2024, 45(5): 130-135.  doi: 10.12259/j.issn.2095-610X.S20240520
    [6] Wenjuan SONG, Xuejuan MA, Yue SUN, Ying GU, Yujia YE, Shumo LI, Fei GE, Liping LIU, Yue ZHAO, Yu WANG. Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography. Journal of Kunming Medical University, 2023, 44(2): 108-112.  doi: 10.12259/j.issn.2095-610X.S20230217
    [7] Jian ZHAO, Jiubing XIE, Liankai ZHAO. Effects of Ranibizumab and Odix on the Microvascular Structure of the Macular Region. Journal of Kunming Medical University, 2022, 43(9): 141-146.  doi: 10.12259/j.issn.2095-610X.S20220930
    [8] Xiu-qiang YAN, Xiao-fan ZHANG, Yu-ling REN, Juan-juan LI, Li-wei ZHANG. OCT Evaluation on the Establishment of A Mouse Model of Chronic Ocular Hypertension Induced by Magnetic Beads Injection. Journal of Kunming Medical University, 2021, 42(1): 23-28.  doi: 10.12259/j.issn.2095-610X.S20201245
    [9] Zhou Yu E , Yin Li Juan , Yang Hui Bo . . Journal of Kunming Medical University, 2020, 41(02): 168-170.
    [10] Wang Jin Rui , Yang Ying . . Journal of Kunming Medical University, 2019, 40(04): 131-135.
    [11] Zhou Yu E , Zhang Zheng Ming , Liao Gui . The Clinic Effect of 2-Hour Feeding in Premature Infants with Very Low Birth Weight. Journal of Kunming Medical University, 2018, 39(08): 145-148.
    [12] Zhou Yu E , Yang Zhao Yu , Yin Yan Tao . Effect of Continuous Nursing on Extremely Low Birth Weight Preterm infants Infants. Journal of Kunming Medical University, 2018, 39(03): 137-140.
    [13] Liu Jing . Effect of Early Intervention in Neurodevelopment on Motor and Cognitive Development of High Risk Premature Infants. Journal of Kunming Medical University,
    [14] Huang Fu Chang Tao . Clinical Efficacy of 23-Gauge Transconjunctival Sutureless Vitrectomy for Vitreous Hemorrhage. Journal of Kunming Medical University,
    [15] Xiong Han Mei . . Journal of Kunming Medical University,
    [16] Zhu Zhao . . Journal of Kunming Medical University,
    [17] Chen Xian Yu . . Journal of Kunming Medical University,
    [18] . Comparison of the Clinical Characteristics of Newborn Respiratory Distress Syndrome between Full-term and Premature Infants. Journal of Kunming Medical University,
    [19] Zhang Yi . . Journal of Kunming Medical University,
    [20] . . Journal of Kunming Medical University,
  • Cited by

    Periodical cited type(1)

    1. 王学昌,刘文静,赵明俊. 术前血小板参数与分化型甲状腺癌临床病理特征的相关性. 临床耳鼻咽喉头颈外科杂志. 2023(10): 796-800 .

    Other cited types(0)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0400.250.50.7511.25
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 37.7 %FULLTEXT: 37.7 %META: 62.0 %META: 62.0 %PDF: 0.3 %PDF: 0.3 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.7 %其他: 4.7 %其他: 0.1 %其他: 0.1 %China: 5.2 %China: 5.2 %Falkenstein: 0.1 %Falkenstein: 0.1 %上海: 8.8 %上海: 8.8 %东莞: 0.0 %东莞: 0.0 %乌鲁木齐: 0.0 %乌鲁木齐: 0.0 %保定: 0.0 %保定: 0.0 %六安: 0.0 %六安: 0.0 %内华达: 0.0 %内华达: 0.0 %北京: 19.1 %北京: 19.1 %十堰: 0.0 %十堰: 0.0 %南昌: 0.0 %南昌: 0.0 %南阳: 0.0 %南阳: 0.0 %博阿努瓦: 0.0 %博阿努瓦: 0.0 %台州: 0.0 %台州: 0.0 %合肥: 0.0 %合肥: 0.0 %哥伦布: 0.0 %哥伦布: 0.0 %天津: 0.1 %天津: 0.1 %宣城: 0.1 %宣城: 0.1 %密蘇里城: 0.0 %密蘇里城: 0.0 %常州: 0.0 %常州: 0.0 %广州: 0.1 %广州: 0.1 %张家口: 0.9 %张家口: 0.9 %成都: 0.0 %成都: 0.0 %扬州: 0.0 %扬州: 0.0 %昆明: 0.5 %昆明: 0.5 %杭州: 0.1 %杭州: 0.1 %武汉: 0.1 %武汉: 0.1 %深圳: 0.0 %深圳: 0.0 %温州: 0.1 %温州: 0.1 %湖州: 0.0 %湖州: 0.0 %漯河: 0.1 %漯河: 0.1 %石家庄: 0.2 %石家庄: 0.2 %纳苏县: 0.0 %纳苏县: 0.0 %芒廷维尤: 1.7 %芒廷维尤: 1.7 %芝加哥: 0.0 %芝加哥: 0.0 %茂名: 0.0 %茂名: 0.0 %西宁: 3.0 %西宁: 3.0 %贵阳: 0.2 %贵阳: 0.2 %赤峰: 0.0 %赤峰: 0.0 %运城: 0.1 %运城: 0.1 %重庆: 0.0 %重庆: 0.0 %长沙: 0.0 %长沙: 0.0 %驻马店: 54.2 %驻马店: 54.2 %其他其他ChinaFalkenstein上海东莞乌鲁木齐保定六安内华达北京十堰南昌南阳博阿努瓦台州合肥哥伦布天津宣城密蘇里城常州广州张家口成都扬州昆明杭州武汉深圳温州湖州漯河石家庄纳苏县芒廷维尤芝加哥茂名西宁贵阳赤峰运城重庆长沙驻马店

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(1)

    Article Metrics

    Article views (2616) PDF downloads(18) Cited by(1)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return